CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-21 | Scavilla Daniel T President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +60,000 | 60,000 | ||
| 2022-04-19 | Davidar David D Director | Sale | −31,500 | $78.03 | $2.5M | 601,275 |
| 2022-04-08 | Huller Kelly SVP, GC, Corporate Secretary | Exercise or conversion | +2,500 | $15.34 | $38K | 2,500 |
| 2022-04-08 | Huller Kelly SVP, GC, Corporate Secretary | Sale | −2,500 | $75.59 | $189K | 0 |
| 2022-04-08 | Huller Kelly SVP, GC, Corporate Secretary | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −2,500 | 0 | ||
| 2022-03-15 | TOBIN JAMES R Director | Exercise or conversion | +5,308 | $43.58 | $231K | 5,308 |
| 2022-03-15 | TOBIN JAMES R Director | Exercise or conversion | +3,542 | $53.27 | $189K | 8,850 |
| 2022-03-15 | TOBIN JAMES R Director | Sale | −8,850 | $65.47 | $579K | 0 |
| 2022-03-15 | TOBIN JAMES R Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −5,308 | 5,208 | ||
| 2022-03-15 | TOBIN JAMES R Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −3,542 | 21,458 | ||
| 2022-03-14 | Davidar David D Director | Gift | −7,000 | 594,275 | ||
| 2022-03-10 | TOBIN JAMES R Director | Exercise or conversion | +10,000 | $43.58 | $436K | 10,000 |
| 2022-03-10 | TOBIN JAMES R Director | Sale | −10,000 | $70.04 | $700K | 0 |
| 2022-03-10 | TOBIN JAMES R Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −10,000 | 10,516 | ||
| 2022-03-08 | TOBIN JAMES R Director | Exercise or conversion | +4,484 | $43.58 | $195K | 4,484 |
| 2022-03-08 | TOBIN JAMES R Director | Sale | −4,484 | $72.00 | $323K | 0 |
| 2022-03-08 | TOBIN JAMES R Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −4,484 | 20,516 | ||
| 2022-01-27 | Douglas Robert Andrew Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2022-01-27 | ZARRILLI STEPHEN T Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2022-01-27 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 |
Page 12 of 25 · 498 trades